Imago Systems, Inc.

Imago was founded with a mission to deliver breakthrough visualization and characterization technology for post-processing of any grayscale image, including those used in medical, veterinary, and industrial applications. The Company has succeeded in developing a multi-algorithmic product that significantly improves the readability of content in a grayscale image, enabling professionals who rely on these images for critical decision-making to be able to “see beyond the limits of the human vision system.” Imago’s initial human healthcare market focus is on visualization of abnormalities in screening mammograms, for which an FDA clinical trial will soon start. Additionally, Imago is in development of a veterinary product which is expected to launch in early 2018. Other modalities and diseases within human healthcare, as well as product development for industrial applications, will follow.

Company’s Keywords:

medical devices, radiology, medical imaging, mammography, veterinary, breast cancer detection